Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer

Metastatic triple-negative breast cancer (TNBC) is a heterogeneous disease with a poor prognosis and currently with few treatment options. Treatment of these patients is highly based on systemic chemotherapy. Some targeted drugs were recently approved for these patients: two poly(ADP-ribose) polymer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cipriano, Élia, Mesquita, Alexandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989121/
https://www.ncbi.nlm.nih.gov/pubmed/33814914
http://dx.doi.org/10.1177/11782234211002491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989121/
https://www.ncbi.nlm.nih.gov/pubmed/33814914
http://dx.doi.org/10.1177/11782234211002491

Ejemplares similares